2020

1. Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era

   European Journal of Haematology, Vol. 104, Núm. 5, pp. 400-408

2. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)

   British Journal of Haematology, Vol. 188, Núm. 6, pp. 888-897